abstract |
A method for diagnosing whether a subject has stomach cancer, which comprises: measuring in a test sample of the subject the levels of a group of miR gene products consisting of, miR-223, miR-21, miR-103-2, miR-136, miR-125b-2, miR-103-1, miR-222, miR-212 prec, miR-125b-1, miR-100, miR-92-1, miR-96, miR-192, miR -23a, miR-215, miR-7-2, miR-138-2, miR-99b, miR-33b, miR-218-2, miR-92-2, miR-25, miR-191, miR-221 , miR-214, miR-107, miR-24-1 and miR-24-2 where an alteration in the levels of the miR gene group in the stomach tissue sample in relation to the levels of miR gene products corresponding in a control sample, it is indicative that the subject has stomach cancer. |